Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12 weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV.
| Image |  |
|---|---|
| Description | scientific article published on April 2016 |
| Author/s |
author: Qing-Lei Zeng |
| Publication date | April 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |